We are live on
!
Find out more
UOC
UBS O'Connor Portfolio holdings
AUM
$3.76B
1-Year Est. Return
62.41%
This Fund
S&P 500
This Quarter
Est. Return
+8.61%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$5.42B
AUM Growth
-$3.38B
(-38%)
Cap. Flow
-$3.75B
Cap. Flow
% of AUM
-69.25%
Top 10 Holdings %
Top 10 Hldgs %
40.63%
Holding
1,042
New
84
Increased
109
Reduced
414
Closed
284
Avg Time Held Equity + Options
3.7
quarters
Top 10 Avg Time Held Equity + Options
0.5
quarters
Top 20 Avg Time Held Equity + Options
0.8
quarters
Avg Time Held Equity only
3.7
quarters
Top 10 Avg Time Held Equity only
0.5
quarters
Top 20 Avg Time Held Equity only
0.8
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$184M |
| 2 |
STOR
STORE Capital Corporation
STOR
|
+$172M |
| 3 |
First Horizon
FHN
|
+$107M |
| 4 |
COUP
Coupa Software Incorporated
COUP
|
+$96.9M |
| 5 |
AAWW
Atlas Air Worldwide Holdings, Inc.
AAWW
|
+$64.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$572M |
| 2 |
ZEN
ZENDESK INC
ZEN
|
+$456M |
| 3 |
AVLR
Avalara, Inc.
AVLR
|
+$373M |
| 4 |
SWCH
Switch, Inc. Class A Common Stock
SWCH
|
+$271M |
| 5 |
Rogers Corp
ROG
|
+$219M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 25.7% |
| 2 | Technology | 18.31% |
| 3 | Healthcare | 15.11% |
| 4 | Miscellaneous | 11.75% |
| 5 | Real Estate | 10.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
FRSG
251
DELISTED
First Reserve Sustainable Growth Corp. Class A Common Stock
FRSG
| $3.66M | 0.07% |
364,605
| – | – |
2021 Q2
6 quarters
|
|
|
AAC
252
DELISTED
Ares Acquisition Corporation
AAC
| $3.63M | 0.07% |
360,320
-105,769
| -23% | -$1.06M |
2021 Q1
7 quarters
|
|
253
DELISTED
Corner Growth Acquisition Corp. 2 Class A Ordinary Share
TRON
| $3.6M | 0.07% |
350,000
| – | – |
2021 Q3
5 quarters
|
|
254
DELISTED
AvalonBay Communities
AVB
| $3.56M | 0.07% |
22,024
+18,349
| +499% | +$3.12M |
2021 Q2
6 quarters
|
|
255
Insmed
INSM
$21.5B
| $3.51M | 0.06% |
175,752
+58,908
| +50% | +$1.14M |
2022 Q1
3 quarters
|
|
256
Alexandria Real Estate Equities
ARE
$7.59B
| $3.51M | 0.06% |
24,072
-99,051
| -80% | -$14.3M |
2022 Q1
3 quarters
|
|
257
DELISTED
National Storage Affiliates Trust
NSA
| $3.5M | 0.06% |
96,757
-227,063
| -70% | -$8.88M |
2021 Q2
6 quarters
|
|
258
Delta Air Lines
DAL
$52.7B
| $3.45M | 0.06% |
104,855
| – | – |
2020 Q2
10 quarters
|
|
259
ReNew
RNW
$2.51B
| $3.42M | 0.06% |
621,763
+310,024
| +99% | +$1.81M |
2022 Q2
2 quarters
|
|
260
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$822B
| $3.39M | 0.06% |
680,000
-1,220,000
| -64% | -$469M |
2019 Q4
12 quarters
|
|
261
DELISTED
Armada Acquisition Corp. I Common Stock
AACI
| $3.38M | 0.06% |
330,834
-3,238
| -1% | -$32.3K |
2021 Q4
4 quarters
|
|
262
GCT Semiconductor Holding
GCTS
$178M
| $3.37M | 0.06% |
330,834
-3,238
| -1% | -$32.7K |
2022 Q1
3 quarters
|
|
|
VRNA
263
DELISTED
Verona Pharma
VRNA
| $3.37M | 0.06% |
128,926
+17,000
| +15% | +$226K |
2022 Q3
1 quarter
|
|
264
DELISTED
Axonics, Inc. Common Stock
AXNX
| $3.35M | 0.06% |
53,602
+20,989
| +64% | +$1.39M |
2022 Q1
3 quarters
|
|
265
Kite Realty
KRG
$4.83B
| $3.35M | 0.06% |
+158,918
| New | +$3.24M |
2022 Q4
0 quarters
|
|
|
MTVC
266
DELISTED
Motive Capital Corp II
MTVC
| $3.32M | 0.06% |
324,361
-3,174
| -1% | -$32.1K |
2022 Q1
3 quarters
|
|
267
DELISTED
Everest Consolidator Acquisition Corporation
MNTN
| $3.32M | 0.06% |
324,361
-3,174
| -1% | -$32.1K |
2022 Q1
3 quarters
|
|
268
Treace Medical Concepts
TMCI
$267M
| $3.29M | 0.06% |
143,309
+10,672
| +8% | +$246K |
2022 Q1
3 quarters
|
|
269
Halozyme
HALO
$12.6B
| $3.26M | 0.06% |
57,337
-26,600
| -32% | -$1.36M |
2022 Q1
3 quarters
|
|
270
DELISTED
American Oncology Network, Inc. Class A Common Stock
AONC
| $3.24M | 0.06% |
322,718
-3,227
| -1% | -$32K |
2021 Q2
6 quarters
|
|
271
Invitation Homes
INVH
$15.8B
| $3.2M | 0.06% |
108,097
-242,699
| -69% | -$7.69M |
2020 Q1
11 quarters
|
|
272
United Therapeutics
UTHR
$23.6B
| $3.2M | 0.06% |
11,522
-1,640
| -12% | -$414K |
2022 Q1
3 quarters
|
|
273
DELISTED
NKGen Biotech, Inc. Common Stock
NKGN
| $3.19M | 0.06% |
320,103
| – | – |
2021 Q3
5 quarters
|
|
274
Becton Dickinson
BDX
$51.5B
| $3.17M | 0.06% |
+12,468
| New | +$2.94M |
2022 Q4
0 quarters
|
|
275
CF Industries
CF
$17.3B
| $3.16M | 0.06% |
37,096
-40,541
| -52% | -$4.12M |
2022 Q2
2 quarters
|
|
Similar funds
FNBT
ACI
RC
A
CGL
CB
JCM
MPM
UBS O'Connor's Q4 2022 Portfolio in Review
As of Q4 2022, UBS O'Connor held 1,042 positions worth $5.42B, down 38% from $8.8B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
UBS O'Connor withdrew a net $3.75B in Q4 2022, closing 284 positions and reducing 414 holdings. Its most notable exit was Biohaven Pharmaceutical Holding Company Ltd., an estimated $572M position sold in full.
By sector, the portfolio is most concentrated in Financials at 26% of assets, up from 20% a quarter earlier, followed by Technology and Healthcare.
Against the trend, UBS O'Connor opened a new position in Coupa Software Incorporated worth $128M.
- UBS O'Connor's largest Q4 2022 buy was Coupa Software Incorporated: 1,619,333 shares worth $128M.
- UBS O'Connor added most to Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2022, an estimated $184M increase.
- UBS O'Connor's biggest Q4 2022 reduction was Rogers Corp, cutting an estimated $219M.
- UBS O'Connor fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q4 2022, selling an estimated $572M.
- UBS O'Connor's ten largest holdings make up 41% of its $5.42B portfolio in Q4 2022.
- UBS O'Connor opened 84 new positions and closed 284 in Q4 2022.
- UBS O'Connor's portfolio value fell 38% quarter-over-quarter to $5.42B.
Based on UBS O'Connor's 13F filing for Q4 2022, filed 14 Feb 2023.